A new study suggests that Epidiolex, a CBD-based drug approved by the FDA, could offer relief for veterans suffering from Gulf War Illness (GWI). The research, conducted on rats, indicates Epidiolex’s potential in alleviating cognitive, mood, and pain-related symptoms associated with GWI, a condition linked to chemical exposures during the 1990-1991 Gulf War.